Literature DB >> 26862048

Association between high-sensitivity C-reactive protein and hyperuricemia.

Tuo Yang1, Xiang Ding1, Yi-Lun Wang1, Chao Zeng1, Jie Wei2,3, Hui Li1, Yi-Lin Xiong1, Shu-Guang Gao1, Yu-Sheng Li1, Guang-Hua Lei4.   

Abstract

The aim of the study was to examine the cross-sectional association between high-sensitivity C-reactive protein (hsCRP) and hyperuricemia (HU). The hsCRP was measured by latex turbidity method. Uric acid was detected on Beckman Coulter AU 5800. HU was defined as uric acid ≥416 μmol/L for the male population and ≥360 μmol/L for the female population. A multivariable logistic analysis model was applied to test the association after adjusting for a number of potential confounding factors. A total of 1935 subjects were included in this study. According to the multivariable regression model, the relative odds of the prevalence of HU were increased by 0.56 times in the third quintile (OR 1.56, 95 % CI 1.03-2.38, P = 0.04), 0.55 times in the fourth quintile (OR 1.55, 95 % CI 1.01-2.36, P = 0.04) and 0.96 times in the fifth quintile (OR 1.96, 95 % CI 1.29-2.98, P < 0.01) of hsCRP comparing with the lowest quintile, and P for trend was smaller than 0.01. In the male population, a positive association existed in the highest quintile of hsCRP (OR 1.66, 95 % CI 1.04-2.66, P = 0.04), and P for trend was 0.07. In the female population, the multivariable-adjusted ORs (95 % CI) of HU in the fourth and fifth quintile of hsCRP were 3.02 (95 % CI 1.09-8.35, P = 0.03) and 3.66 (95 % CI 1.36-9.89, P = 0.01), respectively, and P for trend was smaller than 0.01. The findings of this cross-sectional study suggest that the hsCRP level is positively associated with the prevalence of HU. Level of evidence Cross-sectional study, Level III.

Entities:  

Keywords:  Cross-sectional study; High-sensitivity C-reactive protein; Hyperuricemia

Mesh:

Substances:

Year:  2016        PMID: 26862048     DOI: 10.1007/s00296-016-3429-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  32 in total

1.  Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events.

Authors:  Samia Mora; Nader Rifai; Julie E Buring; Paul M Ridker
Journal:  Circulation       Date:  2006-07-24       Impact factor: 29.690

2.  JAMA patient page. Gout.

Authors:  Ryszard M Pluta; Robert H Shmerling; Alison E Burke; Edward H Livingston
Journal:  JAMA       Date:  2012-11-28       Impact factor: 56.272

Review 3.  New insights into uric acid effects on the progression and prognosis of chronic kidney disease.

Authors:  Vassilis Filiopoulos; Dimitrios Hadjiyannakos; Dimosthenis Vlassopoulos
Journal:  Ren Fail       Date:  2012-01-20       Impact factor: 2.606

4.  Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2.

Authors:  W L Roberts; L Moulton; T C Law; G Farrow; M Cooper-Anderson; J Savory; N Rifai
Journal:  Clin Chem       Date:  2001-03       Impact factor: 8.327

5.  A cohort study of hyperuricemia in middle-aged South Korean men.

Authors:  Seungho Ryu; Yoosoo Chang; Yiyi Zhang; Soo-Geun Kim; Juhee Cho; Hee Jung Son; Hocheol Shin; Eliseo Guallar
Journal:  Am J Epidemiol       Date:  2011-12-12       Impact factor: 4.897

6.  Gout-associated uric acid crystals activate the NALP3 inflammasome.

Authors:  Fabio Martinon; Virginie Pétrilli; Annick Mayor; Aubry Tardivel; Jürg Tschopp
Journal:  Nature       Date:  2006-01-11       Impact factor: 49.962

7.  Dietary magnesium and fiber intakes and inflammatory and metabolic indicators in middle-aged subjects from a population-based cohort.

Authors:  Simona Bo; Marilena Durazzo; Sabrina Guidi; Monica Carello; Carlotta Sacerdote; Barbara Silli; Rosalba Rosato; Maurizio Cassader; Luigi Gentile; Gianfranco Pagano
Journal:  Am J Clin Nutr       Date:  2006-11       Impact factor: 7.045

8.  Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study.

Authors:  E W Campion; R J Glynn; L O DeLabry
Journal:  Am J Med       Date:  1987-03       Impact factor: 4.965

9.  Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based Colaus study.

Authors:  Tanica Lyngdoh; Pedro Marques-Vidal; Fred Paccaud; Martin Preisig; Gérard Waeber; Murielle Bochud; Peter Vollenweider
Journal:  PLoS One       Date:  2011-05-20       Impact factor: 3.240

Review 10.  Blocking IL-1 in systemic inflammation.

Authors:  Charles A Dinarello
Journal:  J Exp Med       Date:  2005-05-02       Impact factor: 14.307

View more
  5 in total

1.  Sex-Specific Associations of Circulating Uric Acid with Risk of Diabetes Incidence: A Population-Based Cohort Study from Sweden.

Authors:  Ning Chen; Iram Faqir Muhammad; Zhibin Li; Peter M Nilsson; Yan Borné
Journal:  Diabetes Metab Syndr Obes       Date:  2020-11-12       Impact factor: 3.168

2.  Markers of Iron Status Are Associated with Risk of Hyperuricemia among Chinese Adults: Nationwide Population-Based Study.

Authors:  Xiangping Li; Tingchao He; Kai Yu; Qian Lu; Rashad Alkasir; Guifang Guo; Yong Xue
Journal:  Nutrients       Date:  2018-02-09       Impact factor: 5.717

3.  Higher Levels of High-Sensitivity C-Reactive Protein Is Positively Associated with the Incidence of Hyperuricemia in Chinese Population: A Report from the China Health and Retirement Longitudinal Study.

Authors:  Hui-Xu Dai; Zhi-Ying Zhao; Yang Xia; Qi-Jun Wu; Yu-Hong Zhao
Journal:  Mediators Inflamm       Date:  2020-05-20       Impact factor: 4.711

4.  Association between metabolic syndrome and knee osteoarthritis: a cross-sectional study.

Authors:  Dong-Xing Xie; Jie Wei; Chao Zeng; Tuo Yang; Hui Li; Yi-Lun Wang; Hui-Zhong Long; Zi-Ying Wu; Yu-Xuan Qian; Kang-Hua Li; Guang-Hua Lei
Journal:  BMC Musculoskelet Disord       Date:  2017-12-16       Impact factor: 2.362

Review 5.  Uric Acid and Oxidative Stress-Relationship with Cardiovascular, Metabolic, and Renal Impairment.

Authors:  Mihai-Emil Gherghina; Ileana Peride; Mirela Tiglis; Tiberiu Paul Neagu; Andrei Niculae; Ionel Alexandru Checherita
Journal:  Int J Mol Sci       Date:  2022-03-16       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.